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Abstract
Background: The neuroprotective effect of xenon has been demonstrated for glutamatergic
neurons. In the present study it is investigated if dopaminergic neurons, i.e. nerve-growth-factor
differentiated PC-12 cells, are protected as well against hypoxia-induced cell damage in the
presence of xenon.
Results: Pheochromocytoma cells differentiated by addition of nerve growth factor were placed
in a N2-saturated atmosphere, a treatment that induced release of dopamine, reaching a maximum
after 30 min. By determining extracellular lactate dehydrogenase concentration as marker for
concomitant cellular damage, a substantial increase of enzymatic activity was found for N2-treated
cells. Replacement of N2 by xenon in such a hypoxic atmosphere resulted in complete protection
against cellular damage and prevention of hypoxia-induced dopamine release. Intracellular buffering
of Ca2+  using the Ca-chelator 1, 2-bis(2-Aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
tetrakis(acetoxymethyl) ester (BAPTA) reduced the neuroprotective effect of xenon indicating the
essential participation of intracellular Ca2+-ions in the process of xenon-induced neuroprotection.
Conclusions: The results presented demonstrate the outstanding property of xenon to protect
neuron-like cells in a hypoxic situation.
Background
Originally, hypoxia/ischemia-induced alterations in neu-
ronal function have been attributed to be an over-release
of neurotransmitters, including dopamine and glutamate.
Many studies have been performed on the mechanisms of
glutamate-induced neuronal damage [1,2] but relatively
few have investigated the hypoxia-induced damage in
dopaminergic neurons [3-6]. In recent years several lines
of evidence have suggested that effects other than excito-
toxic mechanisms may also participate in hypoxia-
induced cell damage such as cortical spreading depression
[7,8]. Rat pheochromocytoma (PC-12) cells are catecho-
laminergic, excitable cells that have been widely used as
an in vitro model for neuronal cells [9] possessing both
D1- and D2-dopamine receptors [10]. In these cells
hypoxia causes a transient release of dopamine resulting
from a complex cellular response consisting of increased
dopamine release and reduced uptake rate. Such increased
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dopamine concentration has been shown to be associated
with cellular damage indicated by an elevated release of
lactate dehydrogenase (LDH) from the cells [6,11].
Numerous approaches have been undertaken to reduce
hypoxia-induced neurotoxicity [2,12]. The pathological
increase of extracellular neurotransmitter concentration
presents probably one of the first indicators for such dam-
age although it is not clear to what extent it contributes
directly. Thus, a reduction or even complete suppression
of such an increase of neurotransmitter concentration
after the primary neuronal damage would suggest a high
probability for protection from the hypoxic insult.
Recently, we have shown that the noble gas xenon pre-
vents in hypoxic cortical neurons hypoxia-induced cell
damage and glutamate release [13,14]. Such neuroprotec-
tive potential has been confirmed by Ma et al. [15] and
Wilhelm et al.[16], and related to its property of being an
NMDA-receptor antagonist. In the present paper, how-
ever, we show that also in the dopaminergic PC-12-system
xenon exhibits profound neuroprotective properties for
hypoxic cells thus underlining its usefulness as a general
neuroprotectant.
Results
Release of dopamine under hypoxic conditions
Cells kept under normoxic conditions did not release
dopamine during the time period studied. If, however,
they were kept in an atmosphere consisting of 100%
nitrogene, considerable amounts of dopamine were
found in the extracellular space reaching a maximum at
30 min of incubation, followed by a subsequent decrease.
If under the same conditions nitrogen was replaced by
xenon, no such increase in dopamine concentration was
found (Fig. 1a). The level of extracellular dopamine
remained as low as in cells kept under normoxic
conditions.
Hypoxia-induced cellular damage
In order to test if such hypoxia damaged the cells, extracel-
lular LDH was determined after a two-hour period of
treatment. A low level of LDH was found in cells kept
under normoxic conditions whereas cells kept under
nitrogen showed a significant release of LDH indicating
severe cellular damage (Fig. 1b). If instead of nitrogen
xenon was used to create such hypoxic condition, the
LDH level remained at the same low level as in controls.
Effect of the dopamine reuptake inhibitor GBR 1209
Hypoxia-induced extracellular increase of dopamine
could be caused either by elevated release of dopamine or
by a reduced, or even inhibited, dopamine uptake. If
hypoxia caused faster release but did not interfere with
uptake, uptake-inhibitors would cause a higher concen-
tration of dopamine in the extracellular space. On the
other hand, if the release was constant but the re-uptake
inhibited by hypoxia, additional inhibition of uptake by
inhibitors would have no or little effect. In the presence of
5 nM of the dopamine reuptake inhibitor GBR 1209 the
extracellular dopamine concentration did not change in a
normoxic or xenon environment. However, in nitrogen
the extracellular dopamine concentration did not reach
exactly the same value as in pure nitrogen, the dopamine
level was slightly but significantly reduced, thus support-
ing the view that hypoxia-induced extracellular dopamine
increase was caused by an enhanced release of dopamine
and – to a lesser extent – an interference with the uptake
mechanism (Fig. 2).
Effects of the dopamine receptor antagonists SCH 23390 
and sulpiride
To test if indeed the hypoxia-induced increase of extracel-
lular dopamine itself caused the cell damage measured by
the increase in extracellular LDH, dopamine receptor
antagonists were used. Since they prevent dopamine bind-
ing they should provide protection of dopamine-induced
damage. If the D1 receptor antagonist SCH 23390 was
used during the incubation period, then at the highest
dose of 10 nM, a reduction of nitrogen-induced external
LDH-increase could be seen. However, even at this highest
applied dose of SCH 23390, there was still only a less than
50% reduction in extracellular LDH (Fig. 3a). If, on the
other hand, the D2 receptor antagonist sulpiride was
used, no reduction in the nitrogen-induced LDH-release
was found (Fig. 3b). Both compounds did not change the
xenon-induced suppression of cellular damage.
Cellular damage induced by external addition of 
dopamine
To analyze if indeed the increased external dopamine was
detrimental to cells, they were incubated in the presence
of 100 nM dopamine, either for 30 min followed by 120
min in normal medium, or continuously for 150 min. As
shown in fig. 4, column (c), even the 30 min incubation
with 100 nm dopamine (the lesser of the two dopamine
challenges) was sufficient to cause considerable cell dam-
age. Such damage was further increased if dopamine was
present for the whole period of time of 150 min (column
(e). We asked then if xenon not only prevented the release
of dopamine in a hypoxic situation but could even reduce
the damage caused by external dopamine. Cells were incu-
bated for 30 min in normal buffer containing 100 nM
dopamine followed by 120 min in xenon-saturated
buffer, without dopamine. As shown in column (d), the
dopamine-induced damage to the cells as seen in column
(c) was significantly reduced. If the cells were incubated
for 150 min in xenon-saturated buffer containing
dopamine, even under those conditions the damage was
low compared to cells exposed to dopamine in normal
buffer (column (f)).BMC Neuroscience 2004, 5:55 http://www.biomedcentral.com/1471-2202/5/55
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A. Dopamine release from differentiated PC-12 cells under normoxic conditions, in N2, or in xenon Figure 1
A. Dopamine release from differentiated PC-12 cells under normoxic conditions, in N2, or in xenon. Whereas almost no 
dopamine was released from control cells during the two-hour period, a strong increase of extracellular dopamine was found 
when cells were kept in N2. When cells were maintained in a xenon-atmosphere, no dopamine release occurred, there was 
virtually no difference compared to controls. B. Assessment of cellular damage in PC-12 cells after two-hour incubation. If cells 
were kept in normal air, or in xenon, only a small amount of LDH was released. Much higher cellular damage was found when 
cells were incubated in N2. (n = 5; **P < 0.01 with respect to untreated controls).
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Buffering of intracellular Ca2+-ions using BAPTA
In order to test if changes in intracellular Ca2+  were
required for the neuroprotective effect of xenon, cells were
incubated with the cell-permeant Ca-chelator BAPTA-AM.
As shown in fig. 5, chelating intracellular Ca2+ does not
damage the cells per se (control + 10 µM BAPTA). Surpris-
ingly, such chelation reduces significantly the neuropro-
tective effect of xenon, indicating an essential role for
intracellular Ca2+ for this effect to occur. A slight but sig-
nificant reduction in cellular damage is observed when
BAPTA-treated cells are incubated in nitrogen-saturated
buffer.
Comparison with another dopaminergic cell system
To exclude that the results obtained were limited to the
PC-12-system itself, hypoxia-induced dopamine release
and cell damage was investigated in rat embryonic pri-
mary mesencephalic cell cultures that are known to con-
tain 0.5 – 1.5% of dopaminergic cells [26]. As shown in
fig. 6, in an hypoxic atmosphere a very similar pattern of
dopamine and LDH release is obtained compared to PC-
12 cells. Xenon prevents also in these primary cells the
hypoxia-induced neurotransmitter and LDH release.
Discussion
In hypoxia/ischemia a key feature of secondary damage
after the primary neuron-damaging event is the over-
release of neurotransmitters [17]. Consequently, an inter-
ference with the hypoxia-induced release mechanism with
respect to its control systems may be extremely useful to
reduce cellular damage. The results presented here show
that xenon has such properties, namely to prevent cellular
Effect of the dopamine uptake inhibitor GBR 1209 on dopamine release in hypoxic cells Figure 2
Effect of the dopamine uptake inhibitor GBR 1209 on dopamine release in hypoxic cells. If PC-12 cells were incubated in the 
presence of 5 nM of the dopamine uptake inhibitor GBR 1209, no effect was observed in cells incubated under normoxic con-
ditions or in a xenon atmosphere. However, a much higher extracellular dopamine concentration was found in cells incubated 
in N2 and GBR 1209 than in N2 alone, indicating that indeed the release was intensified under hypoxic conditions. (n = 4; P < 
0.0001 with respect to untreated controls, analyzed by 2-way ANOVA and Bonferroni posttests between GBR1209-treated 
and untreated groups).
0 30 60 90 120
0
200
400
600
800
1000
1200
1400
1600
control+ GBR 12909
xenon+ GBR 12909
nitrogen+ GBR 12909
nitrogen
***
time (min)
d
o
p
a
m
i
n
e
 
(
n
M
)
***
***
*** ***
***BMC Neuroscience 2004, 5:55 http://www.biomedcentral.com/1471-2202/5/55
Page 5 of 9
(page number not for citation purposes)
A. Effect of various concentrations of the D1-receptor antagonist SCH 23390 on cell survival after two-hour incubation Figure 3
A. Effect of various concentrations of the D1-receptor antagonist SCH 23390 on cell survival after two-hour incubation. No 
effect was observed on PC-12 cells maintained under normal conditions or in xenon, however, for cells kept in nitrogen, a con-
centration-dependent decrease of cellular damage was found, indicating that the D1-receptor was involved to convey the cellu-
lar damage. (n = 4; **P < 0.01 and *P < 0.05 with respect to untreated controls). B. Effect of various concentrations of the D2-
receptor antagonist sulpiride on cell survival after two-hour incubation. No protective effect of sulpiride was found for cells 
incubated in nitrogen, even a slight increase of cellular damage was seen with increasing concentrations of sulpiride.
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damage and neurotransmitter release in a hypoxic situa-
tion thus qualifying it as an almost ideal early neuropro-
tectant. Concerning possible cellular targets for xenon, a
first indication for the participation of Ca2+-regulated
events was obtained when it was shown that xenon
blocked cells in metaphase and that the block could be
lifted by artificial small intracellular Ca2+- increases [18].
Since the CaM KII complex is known to play a decisive
role in the metaphase/anaphase transition, it was tested if
the CaMKII-inhibitor KN-93 had likewise metaphase-
blocking properties. Such effects were obtained [19]. It is
well known that in dopaminergic differentiated PC-12
cells, the CaMKII complex is involved in the regulation of
neurotransmitter release [20-22] as well as its participa-
tion in a multitude of other Ca2+-dependent regulatory
events [23]. Thus, it appears to be plausible that one of the
targets for xenon might be the CaMKII complex, either
directly or via interference with other Ca2+-dependent sys-
tems. One of those may be the Ca2+/calmodulin-activated
calcineurin system that has been implicated in the regula-
tion of monoamine release [24]. Alternatively, xenon
might interact upstream of these regulatory systems with
other Ca2+-dependent events required to occur in
hypoxia-induced cell damage. Such a scenario is suggested
by our demonstration that the neuroprotective effect of
xenon is strongly reduced if PC-12 cells are loaded with
BAPTA. Thus, at present all evidence obtained by us
[13,14,18,19] and others [15,16] establish a complex and
composite picture of targets susceptible to xenon includ-
ing NMDA receptors, Ca2+-regulating and -regulated sys-
tems up to the activaton of transcription factors whereby
such targets are probably not essentially and sequentially
linked to each other.
To summarize briefly our main findings: (1) The presence
of xenon blocks hypoxia-induced dopamine release in
dopaminergic cells. (2) Hypoxia-induced dopamine
increase is caused by an enhanced release of dopamine
rather than a reduced uptake of dopamine. (3) When
measuring LDH release as a marker of cellular damage,
xenon was found to block such release, which suggests
that xenon reduces hypoxia-induced cellular damage. (4)
Increased extracellular dopamine can damage
Dopamine-induced cellular damage Figure 4
Dopamine-induced cellular damage. Cells were incubated for 
150 min with and without 100 nM dopamine and LDH-
release was determined. (a) untreated control; (b) untreated 
cells kept for 30 min in normoxia followed by 120 min in 
xenon-atmosphere; (c) cells under normoxic conditions 
treated for 30 min with 100 nM dopamine followed by 120 
min in normal medium; (d) cells under normoxic conditions 
treated for 30 min with 100 nM dopamine, followed by 120 
min incubation in xenon-atmosphere in normal medium 
without dopamine; (e) cells under normoxic conditions 
treated for 150 min with 100 nM dopamine; (f) cells under 
normoxic conditions treated for 30 min with 100 nM 
dopamine, followed by 120 min incubation in xenon-atmos-
phere in medium containing 100 nM dopamine. No significant 
difference was found between (a) and (b) whereas the differ-
ence between (c) and (d), and (e) and (f) was highly significant 
(P < 0.0001).
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Effects of intracellular Ca2+-buffering by BAPTA. If PC-12 
cells were preloaded with 10 µM BAPTA, the neuroprotec-
tive effect of xenon was strongly reduced. At the same time, 
however, a small reduction in cellular damage was observed 
in nitrogen-treated cells. (n = 5; P < 0.0001 analyzed by 2-
way ANOVA and Bonferroni posttests between BAPTA-
treated and untreated groups; no significant difference was 
found when the nitrogen-group was compared to the nitro-
gen-BAPTA group).
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A. Dopamine release from mesencephalic dopaminergic cells under normoxic conditions, in N2, or in xenon Figure 6
A. Dopamine release from mesencephalic dopaminergic cells under normoxic conditions, in N2, or in xenon. Mesencephalic 
cells containing dopaminergic neurons were exposed on day 14 after preparation for two hours either to normal atmosphere, 
or xenon or nitrogen. Dopamine was not released from cells maintained under normal conditions or in xenon whereas a signif-
icant amount of dopamine was liberated from cells maintained in nitrogen. B. Cellular damage in mesencephalic dopaminergic 
cells after two-hour incubation. If cells were kept in normal air, or in xenon, only a small amount of LDH was released. Much 
higher cellular damage was found when cells were incubated in nitrogen. (n = 4; **P < 0.01).
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dopaminergic cells directly. This is mainly mediated by
D1 receptor agonism rather than D2. (5) Such direct extra-
cellular dopamine-induced damage can be reduced by the
presence of xenon, even when the increase in extracellular
dopamine has not been caused by an episode of cellular
hypoxia. (6) The above described protective effects of
xenon depend on the presence of calcium ions.
Further studies will show if indeed in the hypoxic cell
multiple intracellular targets exist for xenon and how they
are orchestrated together to result in cellular protection.
Conclusions
Based on the present results obtained with NGF-differen-
tiated PC-12 cells and on the literature cited in this paper,
xenon appears to be a neuroprotectant for a broad spec-
trum of neuronal cells; given its proven non-toxicity based
on its long clinical use, it may come close to fulfilling the
requirements for an ideal or "gold standard"
neuroprotectant.
Methods
Cells
Rat pheochromocytoma cells (PC-12) were maintained in
RPMI 1640 medium containing 5% fetal calf serum, 10%
horse serum, at 37°C, 5% CO2. For experiments, cells
were seeded in 24-well plates at a density of 1 × 105 cells/
well and nerve-growth-factor (Promega, Heidelberg, Ger-
many) was added (0.4 µg/ml) whereupon cells entered
differentiation. They were used on day five after the addi-
tion of growth factor [25]. Primary dopaminergic cells
from rat embryonic brain were prepared as described (26)
and used on day 14.
Determination of dopamine and LDH
Hypoxia-treatment was performed as described [13]. Sam-
ples from individual wells were taken at the intervals indi-
cated and deproteinated using 5% perchloric acid (1:1 =
vol/vol). Supernatants were transferred to Eppendorff
tubes and the same volume (0.5 ml) of 0.4 M perchloric
acid was added, mixed on vortex and centrifuged (6000
rpm, 3 min) to remove cell debris. Dopamine concentra-
tion was determined by high-pressure liquid chromatog-
raphy (Bio-Tek, Neufahrn, Germany) using an
electrochemical detector (Biometra, Göttingen,
Germany). Cellular damage after the experiment was
assessed by measuring spectrophotometrically the con-
centration of LDH in the original supernatant, before the
addition of perchloric acid (Roche Diagnostics, Man-
nheim, Germany).
Chemicals
Gases were supplied by AGA-Linde (Berlin, Germany).
1,2-bis(2-Aminophenoxy)ethane-N,N,N',N'-tetraacetic
acid tetrakis(acetoxymethyl) ester (BAPTA-AM) was pur-
chased from Molecular Probes, (Leiden, The Nether-
lands), and all standard chemical products were obtained
from Merck (Berlin, Germany).
Statistical analysis
All experiments were repeated at least five times, i.e. in
five different plates on five different days. The data were
presented as means ± SEM. The results of multiple groups
were analyzed using one-way ANOVA with Dunnett's
multiple comparison post test or two-way ANOVA with
Bonferroni posttests using GraphPad Prism version 3.00
for Windows, GraphPad Software, San Diego California
USA. Differences with p values less than 0.05 were consid-
ered statistically significant.
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